thirty-five evaluable patients with hairy cell leukemia ( hcl ) were treated with recombinant interferon alfa-2a ( rifn-alpha 2a ) , given at a dose of 3 x 10 ( 6 ) units ( u ) intramuscularly ( im ) daily for 6 months followed by 3 x 10 ( 6 ) u im three times a week for an additional 18 months in a single institution study .
C0023443
hairy cell leukemia
C0021734
recombinant interferon alfa-2a